SCHEMBL5387366

SCHEMBL5387366

CSc1nsc(OCc2ccc(C(C)(C)C)cc2)n1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
APP P05067 1/20 0.42
MEN1 O00255 2/20 0.39
KMT2A Q03164 2/20 0.39
NR4A2 P43354 2/20 0.39
RXRA P19793 2/20 0.39
RXRB P28702 2/20 0.39
L3MBTL1 Q9Y468 3/20 0.39
RAB9A P51151 2/20 0.39
CYP1A2 P05177 2/20 0.38
CYP2C9 P11712 2/20 0.38
CYP2C19 P33261 2/20 0.38
MAPK1 P28482 1/20 0.38
TDP1 Q9NUW8 1/20 0.38
NR4A1 P22736 1/20 0.36
NR4A3 Q92570 1/20 0.36
ALDH1A1 P00352 2/20 0.35
SMN1; SMN2 Q16637 2/20 0.35
NR2F2 P24468 1/20 0.35
CYP3A4 P08684 1/20 0.34
NPSR1 Q6W5P4 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5373469 0.88 MAOB (0.41) MEN1KMT2AL3MBTL1RAB9ACYP1A2
SCHEMBL5417437 0.84 MEN1 (0.41) MEN1KMT2AL3MBTL1RAB9ACYP1A2
SCHEMBL5378069 0.84 CYP1A2 (0.47) MEN1KMT2AL3MBTL1RAB9ACYP1A2
SCHEMBL5381872 0.83 L3MBTL1 (0.56) APPMEN1KMT2AL3MBTL1CYP1A2
SCHEMBL5383575 0.83 APP (0.42) APPMEN1KMT2AL3MBTL1CYP1A2
SCHEMBL5378771 0.83 TDP1 (0.56) APPMEN1KMT2AL3MBTL1RAB9A
SCHEMBL5378052 0.83 MEN1 (0.41) APPMEN1KMT2ARXRARXRB
SCHEMBL5377736 0.82 LMNA (0.47) MEN1KMT2AL3MBTL1RAB9ACYP1A2
SCHEMBL5375690 0.82 RAB9A (0.45) APPMEN1KMT2AL3MBTL1RAB9A
SCHEMBL5398160 0.81 MEN1 (0.39) MEN1KMT2AL3MBTL1RAB9ACYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20070293510-A1 Thiadiazole compounds and use thereof SUMITOMO CHEMICAL COMPANY, LIMITED ( A JAPANESE CORPORATION) (JP) 2007-12-20 US disclosed
US-20070293510-A1 Thiadiazole compounds and use thereof SUMITOMO CHEMICAL COMPANY, LIMITED ( A JAPANESE CORPORATION) (JP) 2007-12-20 US disclosed
US-20070293510-A1 Thiadiazole compounds and use thereof SUMITOMO CHEMICAL COMPANY, LIMITED ( A JAPANESE CORPORATION) (JP) 2007-12-20 US disclosed
US-7273879-B2 Thiadiazole compounds and use thereof SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2007-09-25 US disclosed
US-7273879-B2 Thiadiazole compounds and use thereof SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2007-09-25 US disclosed
US-7273879-B2 Thiadiazole compounds and use thereof SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2007-09-25 US disclosed
US-20050215578-A1 Thiadiazole compounds and use thereof SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2005-09-29 US disclosed
EP-1475374-A1 THIADIAZOLE COMPOUNDS AND USE THEREOF SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2004-11-10 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050215578-A1 Thiadiazole compounds and use thereof C5, C3AR1, TH APP 3076/4885MEN1 2386/4885KMT2A 2219/4885
US-20070293510-A1 Thiadiazole compounds and use thereof C5, C3AR1, TH APP 3108/4885MEN1 2301/4885KMT2A 2234/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.